<DOC>
	<DOC>NCT02515669</DOC>
	<brief_summary>The purpose of this study is to determine the safety and tolerability of BMS-986089 in boys with Duchenne Muscular Dystrophy with any genetic mutation.</brief_summary>
	<brief_title>Study of an Investigational Drug, BMS-986089, in Ambulatory Boys With DMD</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Diagnosed with DMD by a blood test Able to walk without assistance Able to walk up 4 stairs in 8 seconds or less Weigh at least 15 kg Taking corticosteroids for DMD Any behavior or mental issue that will affect the ability to complete the required study procedures Previously or currently taking medications like androgens or human growth hormone Use of a ventilator during the day Unable to have blood samples collected or receive an injection under the skin</criteria>
	<gender>Male</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>